Browse By: Country ι Category ι Tag

Hepatitis Market Research Reports

Hepatitis C Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
Hepatitis is defined as the inflammation of the liver due to an infection by a virus or other causative organism or toxin. Hepatitis C on the other hand, is primarily as a result of the infection by hepatitis C virus (HCV). With a cure rate between 50%-80%, and no commercially available vaccine as of yet, hepatitis C is considered a deadly disease with a moderate to high infection rate. It is the leading cause for liver transplantation in the U.K and North America.  The transmission of this virus in a majority occurs from injectables drug abuse, as the virus can only be transmitted via blood-to-blood contact. The secondary transmission factors include tattooing, sexual contact, healthcare (blood transfusion, organ transplant) mishaps, and other rare unknown cases. HIV infected indi
Published Date: Apr 2025
Published By: Transparency

Price: $5795
Hepatitis Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
Hepatitis is a medical condition characterized by inflammation of the liver which often leads to other complications such as jaundice, anorexia, liver failure and cirrhosis. Hepatitis is generally of two types- acute when it lasts for less than six months and chronic when it lasts for longer period. It can be caused by a group of viruses called as hepatitis viruses which include groups A, B, C, D, and E. The most observed types of this disease are hepatitis A, hepatitis B and hepatitis C. Globally, 350 million people are chronically infected with any one form of hepatitis and around 500,000 people die every year according to World Health Organization. Hepatitis A is a simpler form of which does not lead to chronic infections. Patients suffering from hepatitis A recover within two mont
Published Date: Nov 2020
Published By: Transparency

Price: $5795
Global Hepatitis Vaccine Sales Market Report 2017
Sales, means the sales volume of Hepatitis Vaccine Revenue, means the sales value of Hepatitis Vaccine This report studies sales (consumption) of Hepatitis Vaccine in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering GlaxoSmithKline Sanofi Pasteur Merck Novartis Pfizer Seqirus Protein Sciences ... Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Hepatitis Vaccine in these regions, from 2011 to 2021 (forecast), like United States China Europe Japan Southeast Asia India Split by produ
Published Date: Feb 2017
Published By: QYResearch

Price: $4000
Global Nonalcoholic Steatohepatitis (NASH) Market Research Report 2017
Production, means the output of Nonalcoholic Steatohepatitis (NASH) Revenue, means the sales value of Nonalcoholic Steatohepatitis (NASH) This report studies Nonalcoholic Steatohepatitis (NASH) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Boehringer Ingelheim? Cerenis Therapeutics? Connexios Life Sciences? Genfit? Islet Sciences? Nimbus Therapeutics? Verva Pharmaceuticals? Viking Therapeutics? Astazeneca Plc Galmed Pharmaceuticals Ltd. GENFIT SA Gilead Science Novo Nordisk Immuron Ltd Intercepts Pharmaceuticals Enzo Biochem, Inc Tobira
Published Date: Feb 2017
Published By: QYResearch

Price: $2900
Global Hepatitis Vaccine Market Research Report 2017
Production, means the output of Hepatitis Vaccine Revenue, means the sales value of Hepatitis Vaccine This report studies Hepatitis Vaccine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering GlaxoSmithKline Sanofi Pasteur Merck Novartis Pfizer Seqirus Protein Sciences ... Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Hepatitis Vaccine in these regions, from 2011 to 2021 (forecast), like North America Europe China Japan Southeast Asia India Split by pro
Published Date: Feb 2017
Published By: QYResearch

Price: $2900
Global Hepatitis Partnering 2010 to 2017
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: Feb 2017
Published By: Current Partnering

Price: $1495
Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
Non-alcoholic steatohepatitis (NASH) is liver disease which is categorized under the spectrum of non-alcoholic fatty liver disease (NAFLD). NASH is an advanced form of NAFLD where the liver inflammation occurs owing to fat deposition in liver. The fat accumulation may be induced by genetic abnormalities, metabolic dysfunction, drug induced damages, etc. 
Published Date: Jan 2017
Published By: Transparency

Price: $5795
United States Hepatitis Drugs Market Report 2017
Sales, means the sales volume of Hepatitis Drugs Revenue, means the sales value of Hepatitis Drugs This report studies sales (consumption) of Hepatitis Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering F. Hoffmann-La Roche Gilead Sciences GlaxoSmithKline Johnson & Johnson Merck Novartis Vertex Pharmaceuticals Abbvie Achillion Pharmaceuticals Bristol-Myers Squibb Dynavax Technologies Mitsubishi Tanabe Pharma Market Segment by States, covering California Texas New York Florida Illinois Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Oral Injection Split by applications,
Published Date: Jan 2017
Published By: QYResearch

Price: $3800
Global Hepatitis Drugs Sales Market Report 2017
This report studies sales (consumption) of Hepatitis Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions,
Published Date: Jan 2017
Published By: QYResearch

Price: $4000
Europe Hepatitis Drugs Market Report 2017
This report studies sales (consumption) of Hepatitis Drugs in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries,
Published Date: Jan 2017
Published By: QYResearch

Price: $3900
China Hepatitis Drugs Market Research Report 2017
This report studies Hepatitis Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer.
Published Date: Jan 2017
Published By: QYResearch

Price: $3200
Global Hepatitis Drugs Market Professional Survey Report 2017
Production, means the output of Hepatitis Drugs Revenue, means the sales value of Hepatitis Drugs This report studies Hepatitis Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering F. Hoffmann-La Roche Gilead Sciences GlaxoSmithKline Johnson & Johnson Merck Novartis Vertex Pharmaceuticals Abbvie Achillion Pharmaceuticals Bristol-Myers Squibb Dynavax Technologies Mitsubishi Tanabe Pharma By types, the market can be split into Oral In
Published Date: Jan 2017
Published By: QYResearch

Price: $3500
Global Hepatitis Drugs Market Research Report 2017
Production, means the output of Hepatitis Drugs Revenue, means the sales value of Hepatitis Drugs This report studies Hepatitis Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering F. Hoffmann-La Roche Gilead Sciences GlaxoSmithKline Johnson & Johnson Merck Novartis Vertex Pharmaceuticals Abbvie Achillion Pharmaceuticals Bristol-Myers Squibb Dynavax Technologies Mitsubishi Tanabe Pharma Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Hepatitis Drugs in these
Published Date: Jan 2017
Published By: QYResearch

Price: $2900
Hepatitis A-Pipeline Insights, 2017
DelveInsight’s, “ Hepatitis A-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatitis A. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Hepatitis A. DelveInsight’s Report also assesses the Hepatitis A therapeutics by Monotherapy, Co
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
Hepatitis D-Pipeline Insights, 2017
DelveInsight’s, “ Hepatitis D-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatitis D. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Hepatitis D. DelveInsight’s Report also assesses the Hepatitis D therapeutics by Monotherapy, Co
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
Non-Alcoholic Steatohepatitis-Pipeline Insights, 2017
DelveInsight’s, “ Non-Alcoholic Steatohepatitis-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Non-Alcoholic Steatohepatitis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Non-Alcoholic Steatohepatitis. DelveInsight’s Report also ass
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
Steatohepatitis-Pipeline Insights, 2017
DelveInsight’s, “ Steatohepatitis-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Steatohepatitis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Steatohepatitis. DelveInsight’s Report also assesses the Steatohepatitis therapeutics by
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
Hepatitis C Virus (HCV) Protease Inhibitors-Pipeline Insights, 2017
DelveInsight’s, “Hepatitis C Virus (HCV) Protease Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatitis C Virus (HCV) Protease Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Hepatitis C Virus (HCV) Protease Inhi
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
Hepatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Hepatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hepatitis Report is to understand the market and pipeline status of the drugs around the Hepatitis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Hepatitis. While the leading brands, companies and che
Published Date: Jan 2017
Published By: DelveInsight

Price: $2000
Hepatitis B-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Hepatitis B-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hepatitis B Report is to understand the market and pipeline status of the drugs around the Hepatitis B to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Hepatitis B. While the leading brands, companies
Published Date: Jan 2017
Published By: DelveInsight

Price: $2000

Upcoming Reports

Wheelchair Accessible Vehicle Converters Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Vehicles which are converted in a way that have easy access for wheelchairs are termed as wheelchair accessible vehicles or WAV’s. The vehicles are specially converted from a standard vehicle to WAV in order to accommodate the wheelchair. Wheelchair accessible vehicles are considered as mult
Published By: Transparency
Price: $5795
Enteral Nutrition Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Enteral nutrition pumps also known as enteral feeding pumps are used to deliver nutritious foods containing carbohydrate, protein, fat, vitamin, minerals and water by inserting directly into the stomach or parts of small intestine. Enteral nutrition pumps are recommended to patients suffering from
Published By: Transparency
Price: $5795
Residential Water Treatment Equipment Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2014 - 2020
Increasing industrial and environmental pollution around the world is increasing the need for water treatment. Water pollution due to increasing industrialization and environment pollution is leading to death and spread of diseases. It also adversely affects more than 1 billion of population every
Published By: Transparency
Price: $5795
Steam Boiler System Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
The growing need of effective heating systems as well as the requirement of increasing operating efficiency of residential and commercial complexes has led to the widespread adoption of steam boiler systems. This technology provides high steam temperature and improved pressure parameters to achiev
Published By: Transparency
Price: $5795
Seismic Survey Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
Increasing exploration activities owing to the efforts of oil and gas companies to locate new oil and gas reserves is expected to drive the global seismic survey market during the forecast period. Oil and gas companies use seismic surveys to map and interpret potential petroleum reserves.  P
Published By: Transparency
Price: $5795

Back To Top